QIAGEN powered by
The critical role of evidence-based databases in pharmacogenomics: Ensuring accuracy, consistency, and relevance

QIAGEN Digital Insights Wednesday, October 23, 2024

In the high-stakes field of pharmacogenomics, precision and accuracy are non-negotiable. Evidence-based databases in pharmacogenomics are indispensable tools that enable…

Expert-curation vs. Artificial intelligence in variant classification: Which approach is better for clinical genetic testing labs?

QIAGEN Digital Insights Monday, October 14, 2024

While AI can analyze massive data sets, it lacks the human insight needed for complex, nuanced decisions. In clinical genetic…

New release: HGMD Professional 2024.3 is here!

QIAGEN Digital Insights Wednesday, September 25, 2024

The industry-leading database for germline mutations adds over 7,900 new expert-curated entries with the HGMD Professional 2024.3 release. HGMD Professional…

Streamline clinical immune repertoire analysis with CLC Genomics Workbench

QIAGEN Digital Insights Tuesday, September 17, 2024

As clinical labs face increasing demands to analyze complex immune repertoires, accurate and efficient software tools have become essential. CLC…

New release: COSMIC Actionability v13 now available

QIAGEN Digital Insights Tuesday, September 3, 2024

Over 430 new clinical trials, 50 new therapies, and 9 new fully curated clinically significant somatic genes included in the…

Leaving the data silo: Biomedical relationships made easy

QIAGEN Digital Insights Monday, July 8, 2024

Bioinformaticians know that good data analysis is always founded on good data; even the best chef struggles to make a…

New release: HGMD Professional 2024.2 is here!

QIAGEN Digital Insights Thursday, June 27, 2024

Over 9,000 disease-associated germline mutations have been added to the industry-leading database HGMD Professional 2024. 2 is now available, adding…

Using NGS to identify vector integration sites in the host genome

QIAGEN Digital Insights Friday, June 21, 2024

The integration of viruses, retroviruses, transposable elements or vectors into host genomes is a central feature of genome biology and…

New QCI Interpret 2024 brings significant performance and scalability enhancements for high-throughput NGS

QIAGEN Digital Insights Thursday, May 30, 2024

The latest QCI Interpret 2024 Release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of…

Free pathway analysis: How much do you really save?

QIAGEN Digital Insights Friday, March 15, 2024

What should you expect from your pathway analysis tools? When it comes to data-driven science, your results are only as…

Whole genome sequencing in oncology: Are we there yet?

QIAGEN Digital Insights Wednesday, March 6, 2024

As the cost of an individual genome becomes more attainable, laboratories in North America and Europe are experimenting with offering…

Advancing Clinical NGS: An integrated bioinformatics workflow for cancer genome and exome sequencing

QIAGEN Digital Insights Wednesday, February 14, 2024

Genome and exome sequencing is transforming cancer diagnostics and care. In the first installment of our Advancing Clinical NGS series,…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.